Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein C-like 1 (HNRNPCL1) is a protein that, according to UniProt and the Human Protein Atlas, may play a role in nucleosome assembly by neutralizing basic proteins such as core hnRNPs[3][4]. There is little to no evidence that this protein serves as a therapeutically actionable target, receptor, enzyme, transporter, or transcription factor, nor is there significant information on its involvement in human disease, drug interaction, or clinical biomarker applications[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C-like 1 (HNRNPCL1).